Carlsmed (CARL) EBT (2024 - 2026)

Carlsmed has reported EBT for 3 years, with the latest figure at -$8.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 52.67% year-over-year to -$8.7 million; the trailing twelve-month figure through Mar 2026 stood at -$32.3 million (down 32.61% YoY), and the FY2025 full-year result was -$29.3 million, down 21.54% from the prior year.
• EBT for Q1 2026 stood at -$8.7 million, down from -$8.6 million in the prior quarter.
• The five-year high for EBT was -$4.7 million in Q4 2024, with the low at -$8.7 million in Q1 2026.
• Historically, EBT has averaged -$7.1 million across 3 years, with a median of -$7.2 million in 2024.
• The largest YoY upside for EBT was 5.04% in 2025 against a maximum downside of 84.78% in 2025.
• Carlsmed's EBT stood at -$4.7 million in 2024, then tumbled by 84.78% to -$8.6 million in 2025, then decreased by 0.88% to -$8.7 million in 2026.
• The last three EBT figures came in at -$8.7 million (Q1 2026), -$8.6 million (Q4 2025), and -$8.5 million (Q3 2025), per Business Quant data.